Skip to main content
. Author manuscript; available in PMC: 2012 Jul 11.
Published in final edited form as: Genes Brain Behav. 2011 Jan 24;10(3):375–383. doi: 10.1111/j.1601-183X.2010.00677.x

Table 2.

TABLE 2a. Genes showing significant changes in expression associated with AVP treatment.
Gene Fold change Function
CASP1 -3.40 Cleave and activate IL1
CST7 -2.50 Immune response
LILRB1 -2.25 Immune response
SPA17 -1.68 Immune cell migration and metastasis
LTB 1.56 Immune response
IL13 -1.43 Interleukin 13
IL7 -1.42 Interleukin 7
CEACAM8 -1.37 Immune response
DEFA5 -1.36 Antimicrobial humoral response
CXCL16 -1.36 Chemotaxis, immune response
IL10B -1.31 Interleukin 10 beta
MHC2TA -1.30 Parasite perception, immune response
TABLE 2b. Genes showing consistent and significant changes in expression associated with AVP treatment in at least 3 of the 4 males.
Gene Fold change Function
IGJ -2.77 Immunoglobulin J chain, activation of B lymphocytes
IGK -2.66 Immunoglobulin K chain
IGHA1 -2.51 Immunoglobulin heavy constant alpha 1
IL1B -2.40 Interleukin 1 beta
IL16 -2.20 Interleukin 16, chemoattractant factor
NFIL3 -1.90 Nuclear factor, interleukin 3
CRHR1 -1.86 Corticotropin releasing hormone receptor 1
CD94 -1.86 Antigen preferentially expressed on natural killer cells
TNFα-P6 -1.64 Tumor necrosis factor alpha-induced protein 6
IL10RA -1.64 Interleukin 10 receptor activity
TNFSF13B -1.62 Tumor necrosis factor receptor binding, B cell activation and differentiation
IL6ST -1.60 Interleukin 6 signal transducer
IL15 -1.46 Interleukin 15, T and natural killer cell activation
A2M -1.44 Cytokine transporter